The $15 billion ad-powered AI startup your doctor may already be using
Full text
Loading the full text…
OpenEvidence is booming despite questions about accuracy and ads.
Publisher's summary from Ars Technica AI. Read the full article on Ars Technica AI · More from Ars Technica AI